SetSale | $2,000,000 | (Mar 19, 2026)
Raven.io | $20,000,000 | (Mar 19, 2026)
Manifold Security | $8,000,000 | (Mar 19, 2026)
Certified by Founder
Lodge
Amphix Bio
start up
United States
- Chicago, IL
- 19/12/2025
- Seed
- $12,500,000
Amphix Bio is a preclinical stage company developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), that modifies immunological response and initiates regenerative processes to restore function lost from injury, disease, or aging. These therapies trigger targeted signaling pathways while forming scaffolds to support biological repair. Amphix Bio's goal is to increase human healthspan — the length of time that people can live productive, fulfilling lives.
- Industry Biotechnology Research
- Website https://www.amphixbio.com/
- LinkedIn https://www.linkedin.com/company/amphix-bio/
Related People
Nick SatherFounder
United States -
Chicago, Illinois
I am interested in developing transformative therapies for regenerative medicine
Beautiful.ai | $45,000,000 | (Mar 19, 2026)
xmemory | $4,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
Multiply(US) | $9,500,000 | (Mar 19, 2026)
Respan (formerly Keywords AI) | $5,000,000 | (Mar 19, 2026)
Homaio | $4,135,744 | (Mar 19, 2026)
Foresight(UK) | $25,000,000 | (Mar 19, 2026)
VerbaFlo.AI | $7,000,000 | (Mar 18, 2026)